Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation

Journal of Virology

Volumn 82, Issue 20, 2008, Pages 10143-10152

  Sacre, Karim ^a   Nguyen, Stéphanie ^a,b   Deback, Claire ^c   Carcelain, Guislaine ^a   Vernant, Jean Paul ^b   Leblond, Véronique ^b   Autran, Brigitte ^a   Dhedin, Nathalie ^a,b  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; IMMEDIATE EARLY 1 PROTEIN; IMMEDIATE EARLY PROTEIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PP65; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNITY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RECIPIENT; VIRUS REPLICATION; ADOLESCENT; AGED; ALLOTRANSPLANTATION; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION;

HUMAN HERPESVIRUS 5;

ADOLESCENT; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; VIRUS REPLICATION;

EID: 53749098854     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00688-08     Document Type: Article

References (38)

1. Alizadeh, M., M. Bernard, B. Danic, C. Dauriac, B. Birebent, C. Lapart, T. Lamy, P. Y. Le Prisé, A. Beauplet, D. Bories, G. Semana, and E. Quelvennec. 2002. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 99:4618-4625.
2. Bunde, T., A. Kirchner, B. Hoffmeister, D. Habedank, R. Hetzer, G. Cherepnev, S. Proesch, P. Reinke, H. D. Volk, H. Lehmkuhl, and F. Kern. 2005. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201:1031-1036.
3. Chalandon, Y., S. Degermann, J. Villard, L. Arlettaz, L. Kaiser, S. Vischer, S. Walter, M. H. Heemskerk, R. A. van Lier, C. Helg, B. Chapuis, and E. Roosnek. 2006. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107:389-396.
4. Cobbold, M., N. Khan, B. Pourgheysari, S. Tauro, D. McDonald, H. Osman, M. Assenmacher, L. Billingham, C. Steward, C. Crawley, E. Olavarria, J. Goldman, R. Chakraverty, P. Mahendra, C. Craddock, and P. A. Moss. 2005. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202:379-386.
5. Cwynarski, K., J. Ainsworth, M. Cobbold, S. Wagner, P. Mahendra, J. Apperley, J. Goldman, C. Craddock, and P. A. Moss. 2001. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97:1232-1240.
6. Deback, C., A. M. Fillet, N. Dhedin, B. Barrou, S. Varnous, F. Najioullah, F. Bricaire, and H. Agut. 2007. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood. J. Clin. Virol. 40:173-179.
7. Dumont-Girard, F., E. Roux, R. A. van Lier, G. Hale, C. Helg, B. Chapuis, M. Starobinski, and E. Roosnek. 1998. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 92:4464-4471.
8. Elkington, R., S. Walker, T. Crough, M. Menzies, J. Tellam, M. Bharadwaj, and R. Khanna. 2003. Ex vivo profiling of CD8-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77:5226-5240.
9. + T cells in protection against CMV disease. Blood 101:2686-2692.
10. + T cells following allogeneic hemopoietic stem cell transplantation. Blood 102:3427-3438.
11. Gilbert, M. J., S. R. Riddell, C. R. Li, and P. D. Greenberg. 1993. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol. 67:3461-3469.
12. Gilbert, M. J., S. R. Riddell, B. Plachter, and P. D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720-722.
13. Godthelp, B. C., M. J. van Tol, J. M. Vossen, and P. J. van Den Elsen. 1999. T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires. Blood 94:4358-4369.
14. + T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98:1358-1364.
15. Hakki, M., S. R. Riddell, J. Storek, R. A. Carter, T. Stevens-Ayers, P. Sudour, K. White, L. Corey, and M. Boeckh. 2003. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 102:3060-3067.
16. Hebart, H., S. Daginik, S. Stevanovic, U. Grigoleit, A. Dobler, M. Baur, G. Rauser, C. Sinzger, G. Jahn, J. Loeffler, L. Kanz, H. G. Rammensee, and H. Einsele. 2002. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme- linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 99:3830-3837.
17. Hebart, H., and H. Einsele. 2004. Clinical aspects of CMV infection after stem cell transplantation. Hum. Immunol. 65:432-436.
18. Hochberg, E. P., A. C. Chillemi, C. J. Wu, D. Neuberg, C. Canning, K. Hartman, E. P. Alyea, R. J. Soiffer, S. A. Kalams, and J. Ritz. 2001. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 98:1116-1121.
19. Lacey, S. F., C. La Rosa, W. Zou, M. C. Sharma, J. Martinez, A. Krishnan, G. Gallez-Hawkins, L. Thao, J. Longmate, R. Spielberg. S. J. Forman, A. Limaye, J. A. Zaia, and D. J. Diamond. 2006. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J. Infect. Dis. 194:1410-1421.
20. La Rosa, C., A. P. Limaye, A. Krishnan, J. Longmate, and D. J. Diamond. 2007. Longitudinal assessment of cytomegalovirus (CMV)-specific immune reponses in liver transplant recipients at high risk for late CMV disease. J. Infect. Dis. 195:633-644.
21. Li, C. R., P. D. Greenberg, M. J. Gilbert, J. M. Goodrich, and S. R. Riddell. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979.
22. Lilleri, D., P. Zelini, C. Fornara, G. Comolli, and G. Gerna. 2007. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients. Am. J. Transplant. 7:1997-2005.
23. Ljungman, P. 2002. Prevention and treatment of viral infections in stem cell transplant recipients. Br. J. Haematol. 118:44-57.
24. Mackall, C. L., C. V. Bare, L. A. Granger, S. O. Sharrow, J. A. Titus, and R. E. Gress. 1996. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156:4609-4616.
25. + T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143-149.
26. Mackall, C. L., F. T. Hakim, and R. E. Gress. 1997. T-cell regeneration: all repertoires are not created equal. Immunol. Today 18:245-251.
27. Maecker, H. T., H. S. Dunn, M. A. Suni, E. Khatamzas, C. J. Pitcher, T. Bunde, N. Persaud, W. Trigona, T. M. Fu, E. Sinclair, B. M. Bredt, J. M. McCune, V. C. Maino, F. Kern, and L. J. Picker. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255:27-40.
28. Mocarski, E. S., and C. T. Courcelle. 2001. Virology, 4th ed. Raven Press, New York, NY.
29. Najioullah, F., D. Thouvenot, and B. Lina. 2001. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J. Virol. Methods 92:55-64.
30. Quinnan, G. V., Jr., N. Kirmani, A. H. Rook, J. F. Manischewitz, L. Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. H. Burns. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. Med. 307:7-13.
31. Reddehase, M. J. 2002. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:831-844.
32. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
33. Rice, G. P., R. D. Schrier, and M. B. Oldstone. 1984. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81:6134-6138.
34. Roux, E., F. Dumont-Girard, M. Starobinski, C. A. Siegrist, C. Helg, B. Chapuis, and E. Roosnek. 2000. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96:2299-2303.
35. Sacre, K., G. Carcelain, N. Cassoux, A. M. Fillet, D. Costagliola, D. Vittecoq, D. Salmon, Z. Ahmoura, C. Katlama, and B. Autran. 2005. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 201:1999-2010.
36. Sun, Y., E. Iglesias, A. Samri, G. Kamkamidze, T. Decoville, G. Carcelain, and B. Autran. 2003. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272:23-34.
37. + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
38. Vezys, V., D. Masopust, C. C. Kemball, D. L. Barber, L. A. O'Mara, C. P. Larsen, T. C. Pearson, R. Ahmed, and A. E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203:2263-2269.